Onconova Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
100,003.00
43,707.00
19,849.00
21,450.00
4,024.00
16,970
Total Accounts Receivable
-
-
1,504.00
31.00
59.00
35
Other Current Assets
4,387.00
3,198.00
1,832.00
1,588.00
820.00
760
Total Current Assets
104,390.00
46,905.00
23,185.00
23,069.00
4,903.00
17,765
Net Property, Plant & Equipment
626.00
420.00
248.00
152.00
64.00
9
Total Investments and Advances
125.00
-
-
-
-
-
Other Assets
12.00
12.00
12.00
12.00
12.00
149
Total Assets
105,153.00
47,337.00
23,445.00
23,233.00
4,979.00
17,923
Accounts Payable
3,710.00
4,027.00
3,421.00
5,323.00
6,186.00
Other Current Liabilities
6,628.00
6,232.00
4,184.00
4,837.00
3,790.00
Total Current Liabilities
10,338.00
10,259.00
7,605.00
10,160.00
9,976.00
Other Liabilities
13,915.00
13,456.00
5,000.00
7,946.00
5,864.00
Total Liabilities
24,253.00
23,715.00
12,605.00
18,106.00
15,840.00
Common Equity (Total)
80,413.00
22,748.00
10,010.00
4,297.00
11,691.00
Total Shareholders' Equity
80,413.00
22,748.00
10,010.00
4,297.00
11,691.00
Total Equity
80,900.00
23,622.00
10,840.00
5,127.00
10,861.00
Liabilities & Shareholders' Equity
105,153.00
47,337.00
23,445.00
23,233.00
4,979.00
Accumulated Minority Interest
487.00
874.00
830.00
830.00
830.00
About Onconova Therapeutics
View Profile
